Unifying CRM and EWOC designs for phase I cancer clinical trials
type: Item
instance of: scholarly article
title: Unifying CRM and EWOC designs for phase I cancer clinical trials
zbMATH Open document ID: 1284.62651
author: Pei-Ling Chu
author: Yong Lin
author: Weichung Joe Shih
published in: Journal of Statistical Planning and Inference
publication date: 2009-03-20T00:00:00Z
Mathematics Subject Classification ID: 62P10
zbMATH DE Number: 5530775
zbMATH Keywords: phase I cancer clinical trial
zbMATH Keywords: maximum tolerated dose
zbMATH Keywords: dose-limiting toxicity
zbMATH Keywords: continual reassessment method
zbMATH Keywords: escalation with overdose control
describes a project that uses: EWOC
MaRDI profile type: Publication
full work available at URL: j.jspi.2008.07.005
OpenAlex ID: W2091515145
cites work: Optimal Bayesian-feasible dose escalation for cancer phase I trials
cites work: Miscellanea. On sequential designs in nonlinear problems
cites work: Continual reassessment designs with early termination
cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
cites work: Non-parametric optimal design in dose finding studies
cites work: Prediction Approaches to Sequentially Searching for an Optimal Dose
cites work: Design and Analysis of Phase I Clinical Trials
DOI: 10.1016/J.JSPI.2008.07.005
description: scientific article; zbMATH DE number 5530775